Difference between revisions of "SGp-pathway control state"
From Bioblast
| Line 10: | Line 10: | ||
|info=[[MiPNet21.06 SUIT reference protocol]] | |info=[[MiPNet21.06 SUIT reference protocol]] | ||
}} | }} | ||
{{MitoPedia concepts}} | {{MitoPedia concepts | ||
|mitopedia concept=SUIT state | |||
}} | |||
{{MitoPedia methods}} | {{MitoPedia methods}} | ||
{{MitoPedia O2k and high-resolution respirometry | {{MitoPedia O2k and high-resolution respirometry}} | ||
}} | |||
{{MitoPedia topics}} | {{MitoPedia topics}} | ||
== SGp(L) == | == SGp(L) == | ||
Revision as of 16:18, 13 May 2016
- high-resolution terminology - matching measurements at high-resolution
SGp-pathway control state
Description
SGp: Succinate & Glycerophosphate.
MitoPathway control: CII&GpDH; obtained as PGMSOctGp(Rot)
SUIT protocol: SUIT-RP1, SUIT-RP2
This pathway control state is obtained in the presence of CI-linked and FAO-linked substrates after inhibition of CI by rotenone, which simultaneously inhibits FAO.
Abbreviation: SGp
Reference: MiPNet21.06 SUIT reference protocol
MitoPedia concepts:
SUIT state
SGp(L)
SGp(P)
SGp(E)
- SUIT-RP1_8Gp: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd
- SUIT-RP2_9Rot: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
